RNA interference - great hopes in the fight against hemophilia
Experiments on mice and primates have shown that subcutaneous administration of the experimental drug ALN-AT3 provides dose-dependent prolonged inactivation of antithrombin, contributing to the normalization of blood clotting processes.
15.04.2015